Background Data-sharing mandates from funders and journals have increased in recent years, but little is known about how shared data are used. Existing research has focused on access frameworks, with ...
He is the lead principal investigator of the ALLEGORY study and the lead author and he has also presented the results last Friday at SLEuro. Today, Dr. Richard Furie will take us again through the ...
In this video podcast, EEWorld interviews Supplyframe’s Eric Rimkeit, where he explains the DRAM shortage and a capacitor surplus. Engineers: Work with your procurement team to minimize supply ...
Anthropic CEO Dario Amodei sat down with CBS News for an exclusive interview Friday, hours after Defense Secretary Pete Hegseth declared the company a supply chain risk to national security, which ...
Objectives Nigeria has one of the highest maternal mortality burdens globally. Improving maternal outcomes requires a better understanding of how women experience care across pregnancy, childbirth and ...
Background Internationally, investment in hospital-based services for sexual violence is increasing. However, service ...
Elections: The voting technology company Smartmatic asked a federal judge on Tuesday to dismiss the federal criminal charges against it because they were part of President Trump’s “campaign of ...
Hosted on MSN
Christine Lagarde WSJ interview transcript
For coverage related to this interview: Christine Lagarde Isn’t Done Trying to Fix EuropeChristine Lagarde Says Her ‘Baseline’ Is Finishing ECB Term WSJ: My first question is probably not going to ...
Roberto Mina, MD, details how in the MajesTEC-9 trial, teclistamab monotherapy boosted PFS and OS in relapsed/refractory multiple myeloma, challenging standardized care.
Although English is widely recognized as a global language, hiring practices in English Language Teaching (ELT) often continue to privilege native-speaker status. This qualitative study explores how ...
TD Cowen 46th Annual Health Care Conference March 2, 2026 9:10 AM ESTCompany ParticipantsSean McClain - Founder, CEO, ...
Pembrolizumab plus weekly paclitaxel, with investigator-choice bevacizumab, achieved statistically significant PFS and OS improvements, addressing a high unmet need in platinum-resistant ovarian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results